NCT00624377 - Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice | Biotech Hunter

Enrollment

2,031

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

March 31, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Tiotropium

Tiotropium 18 mcg HandiHaler once daily

Trial Locations (16)

Boehringer Ingelheim Investigational Site, Chan Wha

Boehringer Ingelheim Investigational Site, Chiayi City

Boehringer Ingelheim Investigational Site, Hwa Lian

Boehringer Ingelheim Investigational Site 1, Kaohsiung City

Boehringer Ingelheim Investigational Site 2, Kaohsiung City

Boehringer Ingelheim Investigational Site 3, Kaohsiung City

Boehringer Ingelheim Investigational Site 1, Taichung

Boehringer Ingelheim Investigational Site 2, Taichung

Boehringer Ingelheim Investigational Site, Tainan City

Boehringer Ingelheim Investigational Site 1, Taipiei

Boehringer Ingelheim Investigational Site 2, Taipiei

Boehringer Ingelheim Investigational Site 3, Taipiei

Boehringer Ingelheim Investigational Site 4, Taipiei

Boehringer Ingelheim Investigational Site 5, Taipiei

Boehringer Ingelheim Investigational Site 6, Taipiei

Boehringer Ingelheim Investigational Site, Taoyuan District